Eight Finalists Selected for 24th Annual Gardere MLK Jr. Oratory Competition in Dallas
14 December 2015
Dallas Independent School District’s publication, The Hub, featured the 24th Annual Gardere MLK Jr. Oratory Semifinal Competition held at the school district’s Ada Williams Auditorium on Dec. 8. Fourth- and fifth-grade students representing 15 elementary schools from across the district presented original speeches answering the question, “What would Dr. King say in his campaign speech if he were running for president this year?”
Students advancing to the final competition scheduled for Jan. 15, 2015 at the Majestic Theatre in downtown Dallas are:
- Kywin Brown, fifth grade, Wilmer-Hutchins Elementary
- Jayden Jackson, fifth grade, L.L. Hotchkiss Elementary
- Donna Guevara, fifth grade, John Neely Bryan Elementary
- Guadalupe Zamora, fifth grade, Arcadia Park Elementary
- Marco Mares, fifth grade, William Brown Miller Elementary
- Za’Kiah Bell, fifth grade, J.P. Starks Math, Science and Technology Vanguard
- Lyriq Turner, fifth grade, Charles Rice Learning Center
- Mariah Hickman, fourth grade, Paul L. Dunbar Learning Center
The complete article can be viewed here. For more information about the Gardere MLK Jr. Oratory competition, including video of past winning speeches, click here.
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”